Description
Cardarine (Endurabol) 25mg — oxymetholone from the manufacturer at 25 mg. Fast-acting oral with dramatic EPO stimulation and strength onset within 3–5 days. 4–6 week kickstart compound; never standalone. TUDCA support mandatory.
Key Benefits
- PPARδ agonist — technically NOT a SARM (no AR binding)
- Dramatic endurance enhancement — marathon-level cardio improvement
- Fatty-acid oxidation up; does not suppress HPTA
- No PCT required
- Cancer concerns from rodent studies at 20× human dose — decide with open eyes
- Each unit dosed at 25 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 10–20 mg/day, single daily dose or split. Cycles 8–12 weeks. Dose pre-cardio for acute enhancement.
How It Works
GW-501516, PPARδ (peroxisome proliferator-activated receptor delta) agonist. Mechanism unrelated to SARMs despite market grouping — does not touch AR. Upregulates fatty-acid oxidation, mitochondrial biogenesis, and muscle fibre-type remodeling.
Pharmacokinetics
Plasma half-life approximately 16–24 hours. Once-daily dosing. Steady-state 5 days.
Potential Side Effects
Clean for HPTA, liver, and lipids at research doses. Rodent carcinogenicity studies at supraphysiological doses (20× human equivalent) — interpret with context. No recommended human use outside research framing.
Cycle & Stacking Guide
Stacks with SARMs for recomp, or with AAS cycles for cardio support on compounds that hurt endurance (tren, trenbolone especially). Standalone during cutting phases.
Storage & Handling
Store in the original blister or bottle at 15–25 °C, away from direct sunlight, heat, and humidity. Oral preparations lose potency faster if exposed to moisture; keep the desiccant (if included) with the tablets. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.